Bengt I. Samuelsson

In 2000, Bengt I. Samuelsson was appointed as the chairman of the board of the Nobel Foundation. This role allowed him to influence the process of awarding Nobel prizes, ensuring their impact and significance in the world of science and beyond. His leadership in this capacity was crucial in maintaining the prestige of the Nobel awards.

In 1997, Bengt I. Samuelsson joined the Board of Trustees of RIKEN, Japan's leading research institution. As a trustee, he contributed to guiding the scientific and strategic direction of one of the world's foremost organizations in innovative and interdisciplinary research. This position demonstrated his global influence in science.

In 1990, Bengt I. Samuelsson received an honorary doctorate from the University of Edinburgh in recognition of his significant contributions to medicine and biochemistry. This honor highlighted his global impact in the scientific community and the lasting influence of his research on future generations of scientists.

On October 11, 1982, Bengt I. Samuelsson was awarded the Nobel Prize in Physiology or Medicine along with Sune K. Bergström and John R. Vane. They were recognized for their discoveries concerning prostaglandins and related substances, key to understanding diverse physiological processes and conditions such as inflammation and blood pressure regulation.

In 1981, Samuelsson became a member of the Royal Swedish Academy of Sciences. This esteemed institution plays a crucial role in scientific advancement and the Nobel Prize. Membership is a prestigious honor, reflecting significant contributions to global scientific knowledge, a recognition Samuelsson earned through his pioneering work.

In 1975, Bengt I. Samuelsson was appointed as a professor of medical chemistry at Karolinska Institute. His work during this period involved extensive research into eicosanoids, focusing on the biosynthesis and role of these lipid mediators in health and disease. His professorship was a testament to his leadership in biochemistry.

In 1967, Bengt I. Samuelsson, along with his colleagues, discovered thromboxanes, a group of lipid compounds derived from arachidonic acid. Thromboxanes play a key role in blood clotting and the cardiovascular system. This discovery was part of his extensive research into eicosanoids, which significantly advanced medical science.

Bengt I. Samuelsson completed his Ph.D. at Stockholm University in 1960. His doctoral work focused on lipid biochemistry, specifically with arachidonic acid and its derivatives, which later became central themes in his research. His doctorate marked the beginning of his influential contributions to biomedical science.

In 1952, Bengt I. Samuelsson began his higher education at Stockholm University where he pursued studies in chemistry. This marked the start of his academic journey in the sciences, which eventually led him to make significant discoveries in the field of biochemistry. His education at Stockholm University was pivotal in shaping his scientific career.

Bengt I. Samuelsson was born on May 21, 1934, in Halmstad, Sweden. Samuelsson is a renowned biochemist who later made groundbreaking contributions to the field of medicine, particularly in understanding the role of certain fatty acids in the human body. His early life in Sweden set the foundation for his illustrious career in scientific research and discovery.